These observations support the inclusion of MC1R in the panel of markers for the diagnosis of uveal melanoma. Therapeutic use of MC1R-specific antibodies targeting cytokine-induced MC1R potentially requires expression of the target molecule on the surfaces of tumor cells. Data presented here support MC1R as a new marker and a putative therapeutic target for uveal melanoma.

We report a case of bacillary angiomatosis in a 32-year-old HIV-positive black Haitian male. Radiologic and pathologic features are presented.

No abstract